{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:31:50Z","timestamp":1789047110582,"version":"build-2803163510"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:00:00Z","timestamp":1682726400000},"content-version":"am","delay-in-days":393,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HG008958"],"award-info":[{"award-number":["T32 HG008958"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Veterinary Cardiology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jvc.2021.05.003","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T15:01:55Z","timestamp":1621609315000},"page":"2-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A review of the underlying genetics and emerging therapies for canine cardiomyopathies"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8106-2048","authenticated-orcid":false,"given":"L.","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H.","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Meurs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sleeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Vulpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0921-4796","authenticated-orcid":false,"given":"C.J.","family":"Martyniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7430-124X","authenticated-orcid":false,"given":"C.A.","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvc.2021.05.003_bib1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCRESAHA.117.309711","article-title":"Classification, epidemiology, and global burden of cardiomyopathies","volume":"121","author":"McKenna","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jvc.2021.05.003_bib2","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.108.804617","article-title":"Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006","volume":"119","author":"Maron","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2021.05.003_bib3","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1016\/j.jvc.2015.03.008","article-title":"Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study)","volume":"17","author":"Payne","year":"2015","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2021.05.003_bib4","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","article-title":"American college of cardiology\/European society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American college of cardiology foundation task force on clinical expert consensus documents and the European S","volume":"42","author":"Maron","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2021.05.003_bib5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2021.05.003_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.14740\/cr578w","article-title":"Feline Hypertrophic Cardiomyopathy: a spontaneous large animal model of human HCM","volume":"8","author":"Freeman","year":"2017","journal-title":"Cardiol Res"},{"key":"10.1016\/j.jvc.2021.05.003_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1939-1676.2010.0479.x","article-title":"Prevalence of dilated cardiomyopathy in Doberman Pinschers in various age groups","volume":"24","author":"Wess","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2021.05.003_bib8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/jsap.12841","article-title":"An update on canine cardiomyopathies \u2013 is it all in the genes?","volume":"59","author":"Dutton","year":"2018","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.jvc.2021.05.003_bib9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2460\/javma.236.4.430","article-title":"Ambulatory electrocardiographic evaluation of clinically normal adult Boxers","volume":"236","author":"Stern","year":"2010","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2021.05.003_bib10","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1939-1676.2012.01026.x","article-title":"Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (the PROTECT study)","volume":"26","author":"Summerfield","year":"2012","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2021.05.003_bib11","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/jvim.12385","article-title":"Natural history of arrhythmogenic right ventricular cardiomyopathy in the boxer dog: a prospective study","volume":"28","author":"Meurs","year":"2014","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2021.05.003_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/vr.100937","article-title":"Arrhythmogenic right ventricular cardiomyopathy in boxer dogs: a retrospective study of survival","volume":"172","author":"Caro-Vadillo","year":"2013","journal-title":"Vet Rec"},{"key":"10.1016\/j.jvc.2021.05.003_bib13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1748-5827.2010.00966.x","article-title":"Canine dilated cardiomyopathy: a retrospective study of prognostic findings in 367 clinical cases","volume":"51","author":"Martin","year":"2010","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.jvc.2021.05.003_bib14","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2006.10.073","article-title":"Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications. Cardiomyopathies: therapeutics based on molecular phenotype","volume":"49","author":"Ashrafian","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2021.05.003_bib15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/GIM.0b013e3181f2481f","article-title":"Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals","volume":"12","author":"Hershberger","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.jvc.2021.05.003_bib16","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/hmg\/ddi386","article-title":"A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy","volume":"14","author":"Meurs","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jvc.2021.05.003_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygeno.2007.04.007","article-title":"A substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy","volume":"90","author":"Meurs","year":"2007","journal-title":"Genomics"},{"key":"10.1016\/j.jvc.2021.05.003_bib18","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00439-012-1158-2","article-title":"A splice site mutation in a gene encoding for PDK4, a mitochondrial protein, is associated with the development of dilated cardiomyopathy in the Doberman pinscher","volume":"131","author":"Meurs","year":"2012","journal-title":"Hum Genet"},{"key":"10.1016\/j.jvc.2021.05.003_bib19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00439-019-01973-2","article-title":"A missense variant in the titin gene in Doberman pinscher dogs with familial dilated cardiomyopathy and sudden cardiac death","volume":"138","author":"Meurs","year":"2019","journal-title":"Hum Genet"},{"key":"10.1016\/j.jvc.2021.05.003_bib20","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/jvim.12163","article-title":"Association of dilated cardiomyopathy with the striatin mutation genotype in boxer dogs","volume":"27","author":"Meurs","year":"2013","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2021.05.003_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jvc.2011.04.001","article-title":"Status of therapeutic gene transfer to treat cardiovascular disease in dogs and cats","volume":"13","author":"Sleeper","year":"2011","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2021.05.003_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/gt.2017.97","article-title":"AAV-9 mediated phosphatase-1 inhibitor-1 overexpression improves cardiac contractility in unchallenged mice but is deleterious in pressure-overload","volume":"25","author":"Schwab","year":"2018","journal-title":"Gene Ther"},{"key":"10.1016\/j.jvc.2021.05.003_bib23","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1038\/mt.2014.127","article-title":"Cardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failure","volume":"22","author":"Ishikawa","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.jvc.2021.05.003_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/f1000research.11243.1","article-title":"In\u00a0vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease","volume":"6","author":"Lau","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.jvc.2021.05.003_bib25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/CIRCHEARTFAILURE.112.971325","article-title":"AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling","volume":"6","author":"Fish","year":"2013","journal-title":"Circ Hear Fail"},{"key":"10.1016\/j.jvc.2021.05.003_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science (80-)"},{"key":"10.1016\/j.jvc.2021.05.003_bib27","series-title":"Textb. Vet. Intern. Med","first-page":"874","article-title":"Primary myocardial disease in the dog","author":"Sisson","year":"2000"},{"key":"10.1016\/j.jvc.2021.05.003_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.gene.2019.02.022","article-title":"The R9H phospholamban mutation is associated with highly penetrant dilated cardiomyopathy and sudden death in a spontaneous canine model","volume":"697","author":"Yost","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.jvc.2021.05.003_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/genes10020168","article-title":"A QIL1 variant associated with ventricular arrhythmias and sudden cardiac death in the juvenile rhodesian ridgeback dog","volume":"10","author":"Meurs","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jvc.2021.05.003_bib30","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2460\/javma.248.10.1135","article-title":"Ventricular arrhythmias in Rhodesian Ridgebacks with a family history of sudden death and results of a pedigree analysis for potential inheritance patterns","volume":"248","author":"Meurs","year":"2016","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2021.05.003_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-60879-6","article-title":"Functional consequences of PDK4 deficiency in Doberman Pinscher fibroblasts","volume":"10","author":"Bolfer","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jvc.2021.05.003_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1089\/biores.2017.0023","article-title":"PDK4 deficiency induces intrinsic apoptosis in response to starvation in fibroblasts from Doberman Pinschers with dilated cardiomyopathy","volume":"6","author":"Taggart","year":"2017","journal-title":"Biores Open Access"},{"key":"10.1016\/j.jvc.2021.05.003_bib33","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2460\/javma.2020.257.10.1041","article-title":"Assessment of PDK4 and TTN gene variants in 48 Doberman Pinschers with dilated cardiomyopathy","volume":"257","author":"Meurs","year":"2020","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2021.05.003_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/bcb-2014-0080","article-title":"Deception in simplicity: hereditary phospholamban mutations in dilated cardiomyopathy","volume":"93","author":"Young","year":"2015","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.jvc.2021.05.003_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5483\/BMBRep.2013.46.5.077","article-title":"SERCA2a: a prime target for modulation of cardiac contractility during heart failure","volume":"46","author":"Park","year":"2013","journal-title":"BMB Rep"},{"key":"10.1016\/j.jvc.2021.05.003_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5326\/JAAHA-MS-6506","article-title":"Dilated cardiomyopathy in standard schnauzers: retrospective study of 15 cases","volume":"53","author":"Harmon","year":"2017","journal-title":"J Am Anim Hosp Assoc"},{"key":"10.1016\/j.jvc.2021.05.003_bib37","series-title":"Molecular genetic studies of canine inherited diseases including SAMS, neuronal ceroid lipofuscinosis and dilated cardiomyopathy","author":"Gilliam","year":"2016"},{"key":"10.1016\/j.jvc.2021.05.003_bib38","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/CIRCULATIONAHA.117.031947","article-title":"RBM20 mutations induce an arrhythmogenic dilated cardiomyopathy related to disturbed calcium handling","volume":"138","author":"Van Den Hoogenhof","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2021.05.003_bib39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ygeno.2008.03.007","article-title":"A novel locus for Dilated Cardiomyopathy maps to canine chromosome 8","volume":"91","author":"Werner","year":"2008","journal-title":"Genomics"},{"key":"10.1016\/j.jvc.2021.05.003_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036691","article-title":"Multiple loci are associated with dilated cardiomyopathy in Irish wolfhounds","volume":"7","author":"Philipp","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jvc.2021.05.003_bib41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00439-010-0855-y","article-title":"Genome-wide association identifies a deletion in the 3\u2019 untranslated region of Striatin in a canine model of arrhythmogenic right ventricular cardiomyopathy: identification of Striatin deletion in canine ARVC","volume":"128","author":"Meurs","year":"2010","journal-title":"Hum Genet"},{"key":"10.1016\/j.jvc.2021.05.003_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.06265","article-title":"QIL1 is a novel mitochondrial protein required for MICOS complex stability and cristae morphology","volume":"4","author":"Guarani","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.jvc.2021.05.003_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0735-1097(94)90568-1","article-title":"Inherited ventricular arrhythmias and sudden death in German shepherd dogs","volume":"24","author":"Moise","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2021.05.003_bib44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0008-6363(99)00198-4","article-title":"Inherited arrhythmias in the dog: potential experimental models of cardiac disease","volume":"44","author":"Mo\u00efse","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jvc.2021.05.003_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a017145","article-title":"Genetic modifiers and oligogenic inheritance","volume":"5","author":"Kousi","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jvc.2021.05.003_bib46","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1161\/CIRCRESAHA.120.315855","article-title":"Gene Therapy for the heart: lessons learned and future perspectives","volume":"126","author":"Cannat\u00e0","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jvc.2021.05.003_bib47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","article-title":"Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure","volume":"124","author":"Jessup","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2021.05.003_bib48","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","article-title":"Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial","volume":"387","author":"Greenberg","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jvc.2021.05.003_bib49","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1073\/pnas.100460897","article-title":"Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor","volume":"97","author":"Huang","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jvc.2021.05.003_bib50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamacardio.2016.0008","article-title":"Intracoronary gene transfer of adenylyl cyclase 6 in patients with heart failure","volume":"1","author":"Hammond","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jvc.2021.05.003_bib51","series-title":"Gene silencing","author":"Choi","year":"2012"},{"key":"10.1016\/j.jvc.2021.05.003_bib52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14304\/SURYA.JPR.V4N7.5","article-title":"RNA therapeutics: RNAi and antisense mechanisms and clinical applications","volume":"4","author":"Chery","year":"2016","journal-title":"Postdoc J"},{"key":"10.1016\/j.jvc.2021.05.003_bib53","series-title":"Antisense gene therapy","author":"Liou","year":"2010"},{"key":"10.1016\/j.jvc.2021.05.003_bib54","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/j.2040-4603.2015.tb00638.x","article-title":"The dystrophin complex: structure, function and implications for therapy","volume":"5","author":"Gao","year":"2015","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jvc.2021.05.003_bib55","doi-asserted-by":"crossref","first-page":"R163","DOI":"10.1093\/hmg\/ddy171","article-title":"Exon-skipping advances for Duchenne muscular dystrophy","volume":"27","author":"Echevarr\u00eda","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jvc.2021.05.003_bib56","doi-asserted-by":"crossref","first-page":"562","DOI":"10.15252\/emmm.201505047","article-title":"Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy","volume":"7","author":"Gramlich","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jvc.2021.05.003_bib57","first-page":"1559","article-title":"Genome editing: a perspective on the application of CRISPR\/Cas9 to study human diseases (Review)","volume":"43","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2019","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jvc.2021.05.003_bib58","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jvc.2021.05.003_bib59","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/15476286.2018.1504546","article-title":"PAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures","volume":"16","author":"Gleditzsch","year":"2019","journal-title":"RNA Biol"},{"key":"10.1016\/j.jvc.2021.05.003_bib60","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/pbi.12736","article-title":"New variants of CRISPR RNA-guided genome editing enzymes","volume":"15","author":"Murovec","year":"2017","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.jvc.2021.05.003_bib61","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00335-017-9697-4","article-title":"CRISPR-Cas orthologues and variants: optimizing the repertoire, specificity and delivery of genome engineering tools","volume":"28","author":"Cebrian-Serrano","year":"2017","journal-title":"Mamm Genome"},{"key":"10.1016\/j.jvc.2021.05.003_bib62","first-page":"130","article-title":"DNA double strand break repair via non-homologous end-joining","volume":"2","author":"Davis","year":"2013","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.jvc.2021.05.003_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-019-0705-y","article-title":"Understanding the diversity of genetic outcomes from CRISPR-Cas generated homology-directed repair","volume":"2","author":"Sansbury","year":"2019","journal-title":"Commun Biol"},{"key":"10.1016\/j.jvc.2021.05.003_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2018.00691","article-title":"Methodologies for improving HDR efficiency","volume":"9","author":"Liu","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.jvc.2021.05.003_bib65","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/mt.2015.173","article-title":"Pluribus unum: 50 Years of research, millions of viruses, and one goal-tailored acceleration of AAV evolution","volume":"23","author":"Grimm","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.jvc.2021.05.003_bib66","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/gt.2009.148","article-title":"Progress and prospects: immune responses to viral vectors","volume":"17","author":"Nayak","year":"2010","journal-title":"Gene Ther"},{"key":"10.1016\/j.jvc.2021.05.003_bib67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/1566523218666181003125308","article-title":"Nanomedicine for gene delivery for the treatment of cardiovascular diseases","volume":"19","author":"Yan","year":"2019","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.jvc.2021.05.003_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.jvc.2021.05.003_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nano7050094","article-title":"Recent advances in nanomaterials for gene delivery\u2014a review","volume":"7","author":"Riley","year":"2017","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jvc.2021.05.003_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/diseases6020042","article-title":"Viral vectors in gene therapy","volume":"6","author":"Lundstrom","year":"2018","journal-title":"Diseases"},{"key":"10.1016\/j.jvc.2021.05.003_bib71","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-Associated Virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.jvc.2021.05.003_bib72","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1128\/JVI.77.6.3495-3504.2003","article-title":"Genetic fate of recombinant adeno-associated virus vector genomes in muscle","volume":"77","author":"Schnepp","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.jvc.2021.05.003_bib73","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","article-title":"Emerging issues in AAV-mediated in\u00a0vivo gene therapy","volume":"8","author":"Colella","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jvc.2021.05.003_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v11010028","article-title":"Viral delivery systems for CRISPR","volume":"11","author":"Xu","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.jvc.2021.05.003_bib75","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1093\/nar\/gkv601","article-title":"Development of an intein-mediated split-Cas9 system for gene therapy","volume":"43","author":"Truong","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jvc.2021.05.003_bib76","first-page":"173","article-title":"Retroviral vectors","volume":"53","author":"Kurian","year":"2000","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jvc.2021.05.003_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/mtm.2016.17","article-title":"Production of lentiviral vectors","volume":"3","author":"Merten","year":"2016","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"10.1016\/j.jvc.2021.05.003_bib78","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.jvc.2021.05.003_bib79","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1093\/hmg\/11.20.2355","article-title":"Gene therapy of muscular dystrophy","volume":"11","author":"Chamberlain","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jvc.2021.05.003_bib80","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1172\/JCI38831","article-title":"Preventing and exploiting the oncogenic potential of integrating gene vectors","volume":"119","author":"Modlich","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jvc.2021.05.003_bib81","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/hum.2014.2525","article-title":"Vector integration and tumorigenesis","volume":"25","author":"Von Kalle","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jvc.2021.05.003_bib82","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/mt.2016.55","article-title":"Evaluating the safety of retroviral vectors based on insertional oncogene activation and blocked differentiation in cultured thymocytes","volume":"24","author":"Zhou","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.jvc.2021.05.003_bib83","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to viral gene therapy vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.jvc.2021.05.003_bib84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jvc.2021.05.003_bib85","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/sj.gt.3302364","article-title":"Immune responses to gene therapy vectors: influence on vector function and effector mechanisms","volume":"11","author":"Bessis","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.jvc.2021.05.003_bib86","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/10430340152712719","article-title":"A pilot study of in\u00a0vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency","volume":"13","author":"Raper","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jvc.2021.05.003_bib87","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/43977","article-title":"Virus treatment questioned after gene therapy death","volume":"401","author":"Lehrman","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jvc.2021.05.003_bib88","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jvc.2021.05.002","article-title":"Prevalence, geographic distribution, and impact on lifespan of a dilated cardiomyopathy-associated RNA-binding motif protein 20 variant in genotyped dogs.","volume":"40","author":"Leach","year":"2021","journal-title":"J Vet Cardiol"}],"container-title":["Journal of Veterinary Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273421000576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273421000576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:39:42Z","timestamp":1761705582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1760273421000576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":88,"alternative-id":["S1760273421000576"],"URL":"https:\/\/doi.org\/10.1016\/j.jvc.2021.05.003","relation":{},"ISSN":["1760-2734"],"issn-type":[{"value":"1760-2734","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of the underlying genetics and emerging therapies for canine cardiomyopathies","name":"articletitle","label":"Article Title"},{"value":"Journal of Veterinary Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvc.2021.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}